Shariat Razavi I, Stacul F, Cova M, Artero M, Carraro M, Malalan F, Pozzi Mucelli R, Dalla Palma L
Istituto di Radiologia, Università di Trieste.
Radiol Med. 1998 Jan-Feb;95(1-2):72-81.
We studied renal function and perfusion after the i.v. injection of Gd-DTPA-BMA, a nonionic paramagnetic contrast agent, to assess renal morphology and function in normal subjects, in renal insufficiency patients and in patients with hepatic failure and normal renal function. The latter were chosen because some patients with advanced hepatic failure may suffer from the hepatorenal syndrome, characterized by severe vasoconstriction in the renal cortical vessels. We investigated if dynamic MRI can detect early renal perfusion abnormalities in the patients who will eventually develop this syndrome.
Thirty MR examinations were carried out on 30 subjects after the i.v. injection of Gd-DTPA-BMA. Our series consisted of: 10 normal subjects; 10 renal insufficiency patients; 10 patients with hepatic failure and normal renal function. MR examinations were performed on a Philips ACS II scanner operating at 1.5 T. Two sequences were carried out in all cases: T1-weighted SE and T1-weighted TGE sequences after the bolus injection of .1 mmol/kg contrast agent. Renal longitudinal diameter and parenchymal thickness were measured in all cases and signal intensity time curves were always made. The signal intensity of the cortex, corticomedullary junction, medulla and pyelocaliceal system of each kidney was measured using a region of interest (ROI). The signal intensity curves were made considering quantitative parameters, including the area below the curve (ASC), the peak (P) and the time to peak (T-P).
Longitudinal diameter and parenchymal thickness values were significantly lower in renal insufficiency patients than in normal subjects. Four phases were demonstrated after i.v. contrast agent injection in normal subjects, namely A) the cortical phase, B) the corticomedullary junction phase, C) the medullary phase, D) the pyelocaliceal phase. No signal intensity decrease in the medullary and pyelocaliceal curves was observed in renal insufficiency patients. Signal intensity curves values were lower in hepatic failure patients than in those with normal renal function. Hepatic failure patients could be divided into two groups: 5 patients had low P and ASC values and 4 had normal P and ASC values. The patients with lower P and ASC values developed the hepatorenal syndrome within a few months of the MR examination.
Signal intensity decreased in the pyelocaliceal system phase in normal subjects because of the high paramagnetic contrast agent concentration. The lack of signal intensity decrease in renal insufficiency patients was caused by the reduced capability of concentrating Gd-DTPA-BMA. Lower signal intensity values in hepatic failure patients may be considered an early sign of the hepatorenal syndrome.
我们在静脉注射非离子型顺磁性造影剂钆喷酸葡胺(Gd - DTPA - BMA)后研究了肾功能和灌注情况,以评估正常受试者、肾功能不全患者以及肝功能衰竭但肾功能正常患者的肾脏形态和功能。选择后者是因为一些晚期肝功能衰竭患者可能会出现肝肾综合征,其特征为肾皮质血管严重血管收缩。我们研究了动态磁共振成像(MRI)能否检测出最终会发展为此综合征的患者早期肾脏灌注异常。
对30名受试者静脉注射Gd - DTPA - BMA后进行了30次磁共振检查。我们的研究对象包括:10名正常受试者;10名肾功能不全患者;10名肝功能衰竭但肾功能正常的患者。磁共振检查在一台1.5T的飞利浦ACS II扫描仪上进行。所有病例均进行了两个序列的检查:在静脉注射0.1 mmol/kg造影剂后进行T1加权自旋回波(SE)序列和T1加权快速梯度回波(TGE)序列。所有病例均测量了肾脏纵径和实质厚度,并绘制了信号强度时间曲线。使用感兴趣区(ROI)测量每个肾脏的皮质、皮髓质交界区、髓质和肾盂肾盏系统的信号强度。根据包括曲线下面积(ASC)、峰值(P)和达峰时间(T - P)等定量参数绘制信号强度曲线。
肾功能不全患者的纵径和实质厚度值明显低于正常受试者。正常受试者静脉注射造影剂后显示出四个阶段,即A)皮质期,B)皮髓质交界期,C)髓质期,D)肾盂肾盏期。肾功能不全患者的髓质和肾盂肾盏曲线未观察到信号强度降低。肝功能衰竭患者的信号强度曲线值低于肾功能正常的患者。肝功能衰竭患者可分为两组:5名患者的P值和ASC值较低,4名患者的P值和ASC值正常。P值和ASC值较低的患者在磁共振检查后的几个月内发展为肝肾综合征。
正常受试者肾盂肾盏系统期信号强度降低是由于高浓度的顺磁性造影剂。肾功能不全患者信号强度未降低是因为浓缩Gd - DTPA - BMA的能力下降。肝功能衰竭患者较低的信号强度值可能被视为肝肾综合征的早期迹象。